Effects of strain and age on hepatic gene expression profiles in murine models of HFE-associated hereditary hemochromatosis

Genes and Nutrition

Volumn 10, Issue 1, 2015, Pages 1-9

  Lee, Seung Min ^a   Loguinov, Alexandre ^b   Fleming, Robert E ^c   Vulpe, Christopher D ^b  

^a Yonsei University   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AKR J; C57BL 6J; Hereditary hemochromatosis; Iron loading status; Mouse strains

Indexed keywords

COMPLEMENTARY DNA; HFE PROTEIN;

AGE; AKR MOUSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL ADHESION; CELL STRESS; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC STRAIN; GENETIC VARIABILITY; HEMOCHROMATOSIS; HFE GENE; IRON OVERLOAD; KNOCKOUT MOUSE; LIPID METABOLISM; MALE; MOUSE; MURINE MODEL; NONHUMAN; WILD TYPE;

MURINAE; MUS;

EID: 84919951058     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-014-0443-1     Document Type: Article

References (54)

1. Abboud S, Haile DJ (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275:19906–19912
2. Adams LA, Angulo P, Abraham SC, Torgerson H, Brandhagen D (2006a) The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis. Liver Int 26:298–304
3. Adams PC, Passmore L, Chakrabarti S, Reboussin DM, Acton RT, Barton JC, McLaren GD, Eckfeldt JH, Dawkins FW, Gordeuk VR, Harris EL, Leiendecker-Foster C, Gossman E, Sholinsky P (2006b) Liver diseases in the hemochromatosis and iron overload screening study. Clin Gastroenterol Hepatol 4:918–923
4. Ahmad KA, Ahmann JR, Migas MC, Waheed A, Britton RS, Bacon BR, Sly WS, Fleming RE (2002) Decreased liver hepcidin expression in the hfe knockout mouse. Blood Cells Mol Dis 29:361–366
5. Aranda N, Viteri FE, Montserrat C, Arija V (2010) Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain. Ann Hematol 89:767–773
6. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelonning K, Fjosne U, Halvorsen TB, Smethurst HB, Sagen E, Bjerve KS (2001) Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 36:1108–1115
7. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH (1999) Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 116:193–207
8. Beutler E (2006) Hemochromatosis: genetics and pathophysiology. Annu Rev Med 57:331–347
9. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G->A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211–218
10. Bradbear RA, Bain C, Siskind V, Schofield FD, Webb S, Axelsen EM, Halliday JW, Bassett ML, Powell LW (1985) Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J Natl Cancer Inst 75:81–84
11. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DHG, Subramaniam VN, Powell LW, Anderson GJ, Ramm GA (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361:669
12. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP (1996) Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335:1799–1805
13. Bulaj ZJ, Ajioka RS, Phillips JD, LaSalle BA, Jorde LB, Griffen LM, Edwards CQ, Kushner JP (2000) Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 343:1529–1535
14. Burke W, Imperatore G, Reyes M (2001) Iron deficiency and iron overload: effects of diet and genes. Proc Nutr Soc 60:73–80
15. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25:14–15
16. Dupic F, Fruchon S, Bensaid M, Loreal O, Brissot P, Borot N, Roth MP, Coppin H (2002) Duodenal mRNA expression of iron related genes in response to iron loading and iron deficiency in four strains of mice. Gut 51:648–653
17. Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson S, Olsson R, Lindgren S, Loof L, Stal P, Wallerstedt S, Almer S, Sandberg-Gertzen H, Askling J (2003) Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 125:1733
18. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408
19. Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC (1997) The hemochromatosis founder mutation in HLA-H disrupts beta 2-microglobulin interaction and cell surface expression. J Biol Chem 272:14025–14028
20. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. PNAS 95:1472–1477
21. Fleming RE, Sly WS (2002) Mechanisms of iron accumulation in hereditary hemochromatosis. Annu Rev Physiol 64:663–680
22. Fleming RE, Holden CC, Tomatsu S, Waheed A, Brunt EM, Britton RS, Bacon BR, Roopenian DC, Sly WS (2001) Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci USA 98:2707–2711
23. Greenwood DC, Cade JE, Moreton JA, O’Hara B, Burley VJ, Randerson-Moor JA, Kukalizch K, Thompson D, Worwood M, Bishop DT (2005) HFE genotype modifies the influence of heme iron intake on iron status. Epidemiology 16:802–805
24. Gross CN, Irrinki A, Feder JN, Enns CA (1998) Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J Biol Chem 273:22068–22074
25. Hann HW, Stahlhut MW, Hann CL (1990) Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology 11:566–569
26. Houglum K, Ramm GA, Crawford DH, Witztum JL, Powell LW, Chojkier M (1997) Excess iron induces hepatic oxidative stress and transforming growth factor beta1 in genetic hemochromatosis. Hepatology 26:605–610
27. Huang C, Li J, Zhang Q, Huang X (2002) Role of bioavailable iron in coal dust-induced activation of activator protein-1 and nuclear factor of activated T cells: difference between pennsylvania and utah coal dusts. Am J Respir Cell Mol Biol 27:568–574
28. Knutson MD, Vafa MR, Haile DJ, Wessling-Resnick M (2003) Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102:4191–4197
29. Leboeuf RC, Tolson D, Heinecke JW (1995) Dissociation between tissue iron concentrations and transferrin saturation among inbred mouse strains. J Lab Clin Med 126:128–136
30. Lee PL, Beutler E, Rao SV, Barton JC (2004) Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood 103:4669–4671
31. Loguinov A, Mian IS, Vulpe C (2004) Exploratory differential gene expression analysis in microarray experiments with no or limited replication. Genome Biol 5:R18
32. Milward EA, Baines SK, Knuiman MW, Bartholomew HC, Divitini ML, Ravine DG, Bruce DG, Olynyk JK (2008) Noncitrus fruits as novel dietary environmental modifiers of iron stores in people with or without HFE gene mutations. Mayo Clin Proc 83:543–549
33. Muckenthaler M, Roy CN, Custodio AO, Minana B, deGraaf J, Montross LK, Andrews NC, Hentze MW (2003) Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet 34:102–107
34. Mura C, Le Gac G, Scotet V, Raguenes O, Mercier A-Y, Ferec C (2001) Variation of iron loading expression in C282Y homozygous haemochromatosis probands and sib pairs. J Med Genet 38:632–636
35. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G (1985) Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 313:1256–1262
36. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718–724
37. Olynyk JK, St Pierre TG, Britton RS, Brunt EM, Bacon BR (2005) Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging. Am J Gastroenterol 100:837–841
38. Pedersen P, Milman N (2009) Extrinsic factors modifying expressivity of the HFE variant C282Y, H63D, S65C phenotypes in 1,294 Danish men. Ann Hematol 88:957–965
39. Pigeon C, Turlin B, Iancu TC, Leroyer P, Le Lan J, Deugnier Y, Brissot P, Loreal O (1999) Carbonyl-iron supplementation induces hepatocyte nuclear changes in BALB/CJ male mice. J Hepatol 30:926–934
40. Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, Poggiali E, Phung Y, Ganz T, Camaschella C (2007) Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 110:4096–4100
41. Rasmussen ML, Folsom AR, Catellier DJ, Tsai MY, Garg U, Eckfeldt JH (2001) A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 154:739–746
42. Rochette J, Le Gac G, Lassoued K, Ferec C, Robson KJ (2010) Factors influencing disease phenotype and penetrance in HFE haemochromatosis. Hum Genet 128:233–248
43. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21–22
44. Rossi E, Bulsara MK, Olynyk JK, Cullen DJ, Summerville L, Powell LW (2001) Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. Clin Chem 47:202–208
45. Roy CN, Penny DM, Feder JN, Enns CA (1999) The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells. J Biol Chem 274:9022–9028
46. Sanchez M, Villa M, Ingelmo M, Sanz C, Bruguera M, Ascaso C, Oliva R (2003) Population screening for hemochromatosis: a study in 5370 Spanish blood donors. J Hepatol 38:745–750
47. Scotet V, Merour MC, Mercier AY, Chanu B, Le Faou T, Raguenes O, Le Gac G, Mura C, Nousbaum JB, Ferec C (2003) Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol 158:129–134
48. Smith PG, Yeoh GC (1996) Chronic iron overload in rats induces oval cells in the liver. Am J Pathol 149:389–398
49. Stevens RG, Morris JE, Cordis GA, Anderson LE, Rosenberg DW, Sasser LB (2003) Oxidative damage in colon and mammary tissue of the HFE-knockout mouse. Free Radic Biol Med 34:1212–1216
50. Strohmeyer G, Niederau C, Stremmel W (1988) Survival and causes of death in hemochromatosis. Observations in 163 patients. Ann N Y Acad Sci 526:245–257
51. van der AD, Peeters PH, Grobbee DE, Roest M, Voorbij HA, van der Schouw YT (2006) HFE genotypes and dietary heme iron: no evidence of strong gene-nutrient interaction on serum ferritin concentrations in middle-aged women. Nutr Metab Cardiovasc Dis NMCD 16:60–68
52. van Dijk BA, Laarakkers CM, Klaver SM, Jacobs EM, van Tits LJ, Janssen MC, Swinkels DW (2008) Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. Br J Haematol 142:979–985
53. Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, Schatzman RC, Britton RS, Bacon BR, Sly WS (1997) Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta 2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7쟠ells. PNAS 94:12384–12389
54. Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, Duffy DL, Martin NG (2000) Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 66:1246–1258